• Rothe, H; Shapiro, W; Sun, WY; Matalon, A. "CaSR polymorphism Arg990Gly and response to calcimimetic agents in end-stage kidney disease patients with secondary hyperparathyroidism and in cell culture". Personalized Medicine. 2008; 5: 109 (#J0155745)
  • Rothe, H; Mayer, G; Eller, P; Matalon, A. "Genetic make-up of calcium-sensing receptor polymorphic position 990 and parameters of secondary hyperparathyroidism in haemodialysis centres from New York and Innsbruck [Abstract]". Nephrology, dialysis, transplantation. 2007; 22: 191 (#J0150744)
  • Elkayam, Lior; Matalon, Albert; Tseng, Chi-Hong; Axelrod, Felicia. "Prevalence and severity of renal disease in familial dysautonomia". American journal of kidney diseases. 2006; 48: 780 (#J0125313)
  • Cattran, D C; Wang, M M; Appel, G; Matalon, A; Briggs, W. "Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis". Clinical nephrology. 2004; 62: 405 (#J0155823)
  • Matalon, A; Markowitz, G S; Joseph, R E; Cohen, D J; Saal, S D; Kaplan, B; D'Agati, V D; Appel, G B. "Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients". Clinical nephrology. 2001; 56: 271 (#J0155824)
  • Matalon, A; Valeri, A; Appel, G B. "Treatment of focal segmental glomerulosclerosis". Seminars in nephrology. 2000; 20: 309 (#J0155825)
  • Sedlis SP; Lorin J; Matalon A; Chandrasekaran S; Gold J; Santini C; Negron M; Kumar K; Steinberg EH. "Dobutamine stress testing in the cardiac catheterization laboratory". American journal of cardiology. 1996; 78: 340 (#J0010305)

All data from NYU School of Medicine Ehrman Medical Library Faculty Bibliography

NYU Faculty may edit their publications and access other personalized services at

For more information contact:
or see: